BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8388487)

  • 1. Analysis of transcription factors binding to the duplicated PEA1 and PEA3 sites that are required for polyomavirus mutant expression in PCC4 embryonic carcinoma cells.
    Nothias JY; Weinmann R; Blangy D; Melin F
    J Virol; 1993 Jun; 67(6):3036-47. PubMed ID: 8388487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The A enhancer of polyomavirus: protein-protein interactions for the differential early and late promoter function under nonreplicating conditions.
    Shivakumar CV; Das GC
    Intervirology; 1998; 41(2-3):103-9. PubMed ID: 9820844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activity in 3T3, F9, and PCC4 embryonal carcinoma cells: a systematic deletion and linker-scanning study of the polyomavirus enhancer.
    Trotot P; Mechali F; Blangy D; Lacasa M
    Virology; 1994 Aug; 202(2):724-34. PubMed ID: 8030236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal subenhancer requirements for high-level polyomavirus DNA replication: a cell-specific synergy of PEA3 and PEA1 sites.
    Rochford R; Davis CT; Yoshimoto KK; Villarreal LP
    Mol Cell Biol; 1990 Sep; 10(9):4996-5001. PubMed ID: 2167444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription enhancer factor-1 (TEF-1) DNA binding sites can specifically enhance gene expression at the beginning of mouse development.
    Mélin F; Miranda M; Montreau N; DePamphilis ML; Blangy D
    EMBO J; 1993 Dec; 12(12):4657-66. PubMed ID: 8223475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins.
    Martin ME; Piette J; Yaniv M; Tang WJ; Folk WR
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):5839-43. PubMed ID: 2842750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyomavirus enhancer requirements for expression in embryonal carcinoma cells.
    Couture LA; Lehman JM
    Int J Dev Biol; 1993 Mar; 37(1):125-33. PubMed ID: 8389574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEA1 and PEA3 enhancer elements are primary components of the polyomavirus late transcription initiator element.
    Yoo W; Martin ME; Folk WR
    J Virol; 1991 Oct; 65(10):5391-400. PubMed ID: 1654447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of the individual enhancer core sequences of polyomavirus: cell-specific uncoupling of DNA replication from transcription.
    Campbell BA; Villarreal LP
    Mol Cell Biol; 1988 May; 8(5):1993-2004. PubMed ID: 2838739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of nuclear factor EF-1A with the polyomavirus enhancer region.
    Bolwig GM; Hearing P
    J Virol; 1991 Apr; 65(4):1884-92. PubMed ID: 1848308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host range specificity of polyomavirus EC mutants in mouse embryonal carcinoma and embryonal stem cells and preimplantation embryos.
    Mélin F; Kemler R; Kress C; Pinon H; Blangy D
    J Virol; 1991 Jun; 65(6):3029-43. PubMed ID: 1851869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tumor promoting phorbol ester, TPA, enhances polyomavirus DNA replication by activating the function of the viral enhancer.
    Murakami Y; Asano M; Satake M; Ito Y
    Oncogene; 1990 Jan; 5(1):5-13. PubMed ID: 2157181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A factor discriminating between the wild-type and a mutant polyomavirus enhancer.
    Kovesdi I; Satake M; Furukawa K; Reichel R; Ito Y; Nevins JR
    Nature; 1987 Jul 2-8; 328(6125):87-9. PubMed ID: 3037380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells.
    Kryszke MH; Piette J; Yaniv M
    Nature; 1987 Jul 16-22; 328(6127):254-6. PubMed ID: 3037385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancer-mediated role for polyomavirus middle T/small T in DNA replication.
    Chen MC; Redenius D; Osati-Ashtiani F; Fluck MM
    J Virol; 1995 Jan; 69(1):326-33. PubMed ID: 7983726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common features of polyomavirus mutants selected on PCC4 embryonal carcinoma cells.
    Melin F; Pinon H; Reiss C; Kress C; Montreau N; Blangy D
    EMBO J; 1985 Jul; 4(7):1799-803. PubMed ID: 2992943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polyomavirus enhancer-binding protein, PEBP5, responsive to 12-O-tetradecanoylphorbol-13-acetate but distinct from AP-1.
    Asano M; Murakami Y; Furukawa K; Yamaguchi-Iwai Y; Satake M; Ito Y
    J Virol; 1990 Dec; 64(12):5927-38. PubMed ID: 2173774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells.
    Katinka M; Vasseur M; Montreau N; Yaniv M; Blangy D
    Nature; 1981 Apr; 290(5808):720-2. PubMed ID: 6261151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E1A represses wild-type and F9-selected polyomavirus DNA replication by a mechanism not requiring depression of large tumor antigen transcription.
    DePolo NJ; Villarreal LP
    J Virol; 1991 Jun; 65(6):2921-8. PubMed ID: 1851864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and mutational analysis of the polyomavirus core promoter: involvement of nuclear factor-1 in early promoter function.
    Shivakumar CV; Das GC
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1281-90. PubMed ID: 8207394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.